Gilead Sciences Inc. Chief Executive Officer Daniel O’Day said the company’s new HIV prevention drug Yeztugo should be able ...

Patients with HIV who are resistant to all four antiretroviral drug classes face a higher risk for death than those who are ...

I n July, Meghalaya Health and Family Welfare Minister Mazel Ampareen Lyngdoh announced that the State may follow Goa in ...

The HIV epidemic in the Philippines continues to escalate, with new cases increasing by 500 percent over the past decade.

When it comes to HIV prevention, the U.S. Supreme Court appeared to back up the task force with its July 11 ruling in Kennedy ...

THE European Medicines Agency on Friday recommended authorizing a twice-yearly injectable drug “lenacapavir” to prevent HIV and help end the virus’ transmission.

The two-month campaign will follow a weekly thematic approach covering 8 themes across 200 villages, 400 schools, 86 colleges ...

Why an HIV patient advocacy group is suing the Trump administration over a Biden administration legal settlement with Gilead ...

In a meaningful step toward expanding access to inclusive healthcare, KonsultaMD by Metro Pacific Health Tech officially introduced its latest offering, HIV self-test kits, during a ceremonial signing ...

Opinion: By dismantling proven HIV prevention and overdose reduction programs, the Trump administration is replacing science ...

Analysts lift targets for Gilead as HIV sales surge and Yeztugo launch gains traction, supporting a stronger full-year ...

Large numbers of vulnerable HIV patients in South Africa are feared to have dropped off medication, in what campaigners warn ...